HNF1A and diabetes mellitus: Having optimized the exoglycosidase plate-based assay, 1000 blood plasma samples from the HNF1A-MODY cohort were analyzed to assess α1-3,4 fucosylation levels and evaluate their diagnostic performance for the identification of cases with diabetes carrying damaging variants in the HNF1A gene.